We investigated the combined effect of increased brain topical K+ concentration and reduction of the nitric oxide (NO') level caused by nitric oxide scavenging or nitric oxide synthase (NOS) inhibition on regional cerebral blood flow and subarachnoid direct current (DC) potential. Using thiopental anesthetized male Wistar rats with a closed cranial window preparation, brain topical superfusion of a combination of the NO' scavenger hemoglobin (Hb; 2 mmollL) and increased K+ concentration in the artificial cerebrospinal fluid ([K+1A csF) at 35 mmollL led to sudden spontaneous transient ischemic events with a decrease of CBF to 14 ± 7% (n = 4) compared with the baseline (100%). The ischemic events lasted for 53 ± 17 min utes and were associated with a negative subarachnoid DC shift of -7.3 ± 0.6 mV of 49 ± 12 minutes' duration. The combina tion of the NOS inhibitor N-nitro-L-arginine (L-NA, I mmollL) with [K+1A csF at 35 mmollL caused similar spontaneous tran sient ischemic events in 13 rats. When cortical spreading de pression was induced by KCI at a 5-mm distance, a typical cortical spreading hyperemia (CSH) and negative DC shift were measured at the closed cranial window during brain topi cal superfusion with either physiologic artificial CSF (n = 5), or artificial CSF containing increased [K+1A csF at 20 mmollL (n = 4), [K+1A csF at 3 mmollL combined with L-NA (n = 10), [K+1A csF at 10 mmollL combined with L-NA (five of six ani mals) or [K+1A csF at 3 mmollL combined with Hb (three of four animals). Cortical spreading depression induced long-lasting transient ischemia instead of CSH, when brain was su perfused with either [K+1A csF at 20 mmollL combined with Hb (CBF decrease to 20 ± 20% duration 25 ± 21 minutes, n = 4), or [K+1A csF at 20 mmollL combined with L-NA (n = 19). Transient ischemia induced by NOS inhibition and [K+1A csF at 20 mmollL propagated at a speed of 3. 4 ± 0.6 mmlmin, indi cating cortical spreading ischemia (CSI). Although CSH did not change oxygen free radical production, as measured on-line by in vivo lucigenin-enhanced chemiluminescence, CSI re sulted in the typical radical production pattern of ischemia and reperfusion suggestive of brain damage (n = 4). Nimodipine (2 j-Lg/kg body weight/min intravenously) transformed CSI back to CSH (n = 4). Vehicle had no effect on CSI (n = 4). Our data suggest that the combination of decreased NO' levels and increased subarachnoid K+ levels induces spreading depression with acute ischemic CBF response. Thus, a disturbed coupling of metabolism and CBF can cause ischemia. We speculate that CSI may be related to delayed ischemic deficits after subarach noid hemorrhage, a clinical condition in which the release of Hb and K+ from erythrocytes creates a microenvironment simi lar to the one investigated here. Key Words: Cerebral blood flow-Nitric oxide-Potassium-Spreading depression Vasospasm-Migraine-Migrainous stroke-Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like epi sodes (MELAS)-Ischemia-Delayed ischemic deficits Subarachnoid hemorrhage.
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Several investigators have studied the role of nitric oxide (NO') as a possible mediator of CSH (Duckrow, 1993; Fabricius et aI., 1995; Zhang et aI., 1994; Wolf et aI., 1996; Goadsby et aI., 1992; Wahl et aI., 1994; Col onna et aI., 1994; 1997; Meng et aI., 1995) . NO' is pro duced by nitric oxide synthases (NOS). Increased activ ity of constitutively expressed nitric oxide synthase dur ing CSD is likely because intracellular calcium is elevated. Intracellular calcium stimulates nitric oxide synthase. In the above-mentioned studies, NOS inhibi tors were used to lower NO' levels. The results were controversial. In our current study, we have investigated the CBF response to CSD in the barbiturate-anesthetized rat with brain topical superfusion of two different NO' lowering agents: the NOS inhibitor N-nitro-L-arginine (L-NA) and the NO' scavenger hemoglobin (Hb). We found that both the NOS inhibitor and the NO' scavenger reduced CSH by 34% (P < 0.05, n = 10) and 46% (P < 0.1, n = 4), respectively. When either NO'-lowering agent was combined with an increased K+ concentration in the artificial cerebrospinal fluid ([K+]A C SF)' we dis covered that CSH was transformed into cortical spread ing ischemia (CSI). Increased [K+]A C SF without NO' lowering agent did not alter spreading hyperemia. Cor tical spreading ischemia is a newly described phenomenon in which ischemia is the consequence of neuronal/glial depolarization. We speculate that CSI is involved in the delayed ischemic deficits (DID) after subarachnoid hemorrhage (SAH) in which the release of Hb and K+ from erythrocytes produces a microenviron ment similar to the one in our experiments.
METHODS

General
Male Wistar rats (n = 77; 250 to 300 g) were anesthetized with 100 mg/kg thiopental-sodium (Trapanal, BYK Pharma ceuticals, Konstanz, Germany), tracheotomized, and artificially ventilated (Effenberger Rodent Respirator, Effenberger Med Techn. Geratebau, Pfaffing/Attel, Germany). The left femoral artery and vein were cannulated, and a continuous intravenous saline solution (I mL/h) was infused. Body temperature was maintained at 38° ± 0.5°C using a heating pad. Systemic arte rial pressure (RFT Biomonitor, Germany) and end-expiratory Pco2 (Heyer CO2 Monitor EGM I, Bad Ems, Germany) were monitored. A Compact I blood gas analyzer (A VL Medizin technik GmbH, Bad Homburg, Germany) was used to serially measure Pa02, Pae02, and pH. Anesthesia was monitored by blood pressure control and tail pinching.
A craniotomy was performed using a saline-cooled drill, the dura mater was removed, and a closed parietal cranial window was implanted (for details see Lindauer et aI., 1993) . The cor tical surface under the window was continuously superfused with artificial cerebrospinal fluid (ACSF). The millimolar com position of the ACSF was as follows: Ca 2 + 1.5; Mg 2 + 1.2;
HC0 3 -24.5; CI-135; glucose 3.7; and urea 6.7. The K+ con centrations (3, 10, 20, and 35 mmollL) determined the Na+ concentrations (152, 145, 135, and 120 mmollL) . The ACSF was equilibrated with a gas mixture containing 6.6% 02> 5.9% CO2, and 87.5% N2 leading to a P02 of 129.1 ± 12.0 mm Hg, a Pe02 of 33.4 ± 4.6 mm Hg, and pH of 7.38 ± 0.04. The CBF was monitored continuously by a laser-Doppler now probe (Vasamedics BPM 403 A, Troy, MI, U.S.A.) with a spatial resolution of 1 mm 3 and a temporal resolution of 0.1 seconds (Dimagl et aI., 1989) . The direct current (DC) potential was measured at the closed parietal window by a silver silverchloride wire with agar bridge inserted into the space between the cortex and the coverslip. The wire was connected to an electrometer (FD 223, WPI, Sarasota, FL, U.S.A.) and an amplifier (Jens Meyer, Munich, Germany). In five animals of series II, an open cranial window was implanted frontally to monitor CBF (laser-Doppler) and DC potential (kalomel elec trode). In the animals of series III through X, topical KCl (150 mmollL) induced CSD at an open temporooccipital window at a 5-mm distance from the closed parietal window. Systemic arterial pressure, CBF, DC shift, and end-expiratory Pco2 were recorded continuously using a personal computer running the ASYST (Macmillan Software, New York, NY, U.S.A.) data acquisition software and a chart recorder (DASH IV, Astro Med, Inc., West Warwick, RI, U.S.A.). Hemoglobin was freshly prepared from heparinized arterial blood of Wistar rats. The blood was centrifuged (2500 g, 5 minutes, 4°C) and the plasma was discarded. The cells were washed five times with three to four volumes of cold 0.9% NaCI, and the buffy coat was removed. Cells were lysed by sonication. The suspension of lysed cells was subjected to cen trifugation (15000 g, 10 minutes, 4°C) and the pellet removed. The Hb-containing supernatant was transferred by gel chroma tography (Bio-Gel P-6, Bio Rad, Richmond, VA, U.S.A.) to the ACSF. Concentration and composition of Hb were measured by a radiometer (ABL system 625, Radiometer A/S, Copenha gen, Denmark) (total Hb 2.0 ± 0.3 mmollL; oxy-Hb 95.2 ± 1.9%; CO-Hb 2.3 ± 1.3%; met-Hb 2.5 ± 2.0%; deoxy-Hb 0.0 ± 0.0%; 02-sat 100%).
Experimental design
In series I, we started with superfusion of Hb (2 mmollL) and physiologic [K+1 A csF at 3 mmoVL for 30 minutes followed by superfusion of Hb and increased [K+1 A csF at 35 mmol/L ( Fig.   1 ). In series II, a similar protocol was used, but Hb was re placed by L-NA (1 mmollL, Sigma Chemicals, Deisenhofen, Germany). Equilibration time for L-NA was 120 minutes be fore [K+Lc S F was increased to 35 mmollL (Fig. 2) . The CBF and DC changes were measured at the parietal window.
In series III, KCI elicited CSD initially (control conditions), at 50 minutes (during brain topical Hb and [K+1AcsF at 3 mmoll L), and also at 80 minutes (during Hb and [K+1 A csF at 20 mmollL). Finally, cardiac arrest by intravenous KCI was re corded (Fig. 3) .
In series IV through VIII, CSD was elicited at the beginning of the experiment and every 60 minutes afterward. The fourth J. P. DREIER ET AL. CSD after 180 minutes was used for statistical comparison between CBF and DC response during superfusion with either physiologic ACSF (series V). or ACSF containing [K+1A csF at 20 mmollL (series VI). L-NA and [K+1A csF at 3 mmollL (series VII), L-NA and [K+1A csF at 10 mmollL (series VIII), or L-NA and [K+ ] A CSF at 20 mmollL (series IV). Equilibration times for [K+1A csF and L-NA were 60 minutes and 120 minutes, respec tively.
In series IX, the protocol of series IV initially was used. After the CSD at 180 minutes, superfusion with L-NA and [K+1A csF at 20 mmollL continued, and nimodipine (2 j.Lg/kg body weight/min, BAYER, Leverkusen, Germany) or vehicle (23.7 volume-percent alcohol) was infused intravenously. Equilibration time for nimodipine was 60 minutes.
In series X, brain cortex oxygen free radical production was measured by enhanced chemiluminescence (CL). We compared CSH under physiologic conditions with CSI during L-NA and [K+1A csF at 20 mmollL (equilibration times for L-NA and [K+1A csF at 20 mmollL, as in series IV). The DC potential was measured at an open frontal window by a calomel electrode.
Nitric oxide synthase assay
Immediately after the experiment, tissue specimens were re moved from the cortex under the parietal window and from the contralateral cortex in situ by conization to a depth of I mm.
They then were immediately frozen in liquid N2 for later analysis.
The NOS assay was based on assessing the conversion of L-l3Hl-arginine to L-[3Hl-citrulline. Tissue samples of 10 mgl 150 j.LL buffer were homogenized in a Potter-Elvehjem homog enizer with a Teflon pestle, four to five strokes, in ice-cold 0.05 mollL TRIS buffer (pH 7.4) containing 1.15% (weight/volume) KCI, I mmollL ethylenediamine tetraacetic acid, 5 mmollL glucose, 0.1 mmollL D,L-dithiothreitol, 200 U/mL superoxide dismutase, 2 mgIL pepstatin A, 10 mgIL trypsin inhibitor, and 44 mgIL PMSF. The homogenate was centrifuged for 10 min utes in a refrigerated bench microcentrifuge at 2000 g (4°C). The protein concentration was measured at 224 and 236.5 nm using serum albumin as a standard. The detection limit was 5 j.Lg/mL. Determination of NOS activity was performed in a reaction buffer: 50 mmol/L HEPES buffer (pH 7.4), which contained 1 mmollL ethylenediamine tetraacetic acid, 1.25 mmol/L CaCl2, 1 mmollL D,L-dithiothreitol, 1 j.LmollL flavin adenine dinucleo tide, 1 j.Lmol/L calmodulin, 15 j.LmollL 6R-tetrahydrobiopterin, and 1 j.LmollL L-eHlarginine (1 j.LCi final concentration). The supernatant was added to obtain a final protein concentration of 15 to 30 j.Lg/mL in a reaction volume of 150 j.LL. The reaction was initiated by adding the cofactor NADPH to a final con centration of 1 mmollL. Samples were incubated for 30 minutes at 37°C. The reaction was terminated by adding 1 mL of ice cold 100 mmol/L HEPES buffer (pH 5.5) containing 10 mmollL EGTA (stop-buffer). The total volume (I mL) was applied to a 0.5 mL Dowex AG50 WX-8 column (Na+-form), which had been equilibrated with the stop-buffer (minus EGTA). L-[2,3-3Hl-citrulline was eluted twice with 0.5 mL stop-buffer (minus EGTA), and the radioactivity was deter mined by liquid scintillation counting.
The enzyme percent inhibition was calculated by subtraction of enzyme activity in the contralateral cortex (100%) minus enzyme activity in the cortex of the window which was super fused with L-NA.
Enhanced chemiluminescence
Chemiluminescence was recorded using a cooled (-20°C) photomultiplier (Hamamatsu R943-02) with a dark count of 3 J Cereb Blood Flow Metab. Vol. 18. No.9. 1998 cps at -20°C. The counts of the photomultiplier were amplified and counted by a Hewlett-Packard Universal counter (HP 5316 B) connected to a personal computer for data recording and storage. To exclude photons from other sources than brain CL, the animal in the stereotactic frame was housed in a dark box and was covered with aluminum foil. Only the cranial window was left unshielded and was positioned under a reflector, re flecting the photons from the exposed brain onto the photon sensitive area of the photocathode (for details, see Dirnagl et aI., 1995) . Lucigenin (N,N' -dimethylacridinium, Sigma Chemicals) is a standard CL enhancer that produces low levels of light (450 to 500 nm) on reaction with intracellular oxygen free radicals, being particularly sensitive to superoxide radicals. Compared with other methods of radical detection, the advantage of the CL principle is that it is sensitive and has high temporal reso lution, therefore allowing the on-line registration of rapid changes of oxygen free radical production.
Data analysis
Data were analyzed by comparing relative changes of CBF and oxygen free radical production and absolute changes of DC. The CBF changes were calculated in relation to baseline at the onset of the experiment (100%). Mean value comparisons between two sets of data were made using Student's t test. The data were compared for multiplicative effects using a logarith mic transformation. All data in the text, table, and figures are given as mean value ± SD.
RESULTS
Physiologic variables before and at the end of the ex periments are given in Table 1 . Neither brain topical application of L-NA, Hb nor that of increased [K+]A C SF had any significant influence on the systemic variables. Intravenous nimodipine decreased blood pressure sig nificantly (P < 0.01). In the long experiments of series IX, the animals became mildly hypocapnic (P < 0.05). In the normal cascade of ischemia, the decrease of CBF induces first a neuronal hyperpolarization and then a depolarization with a delay of several tens of seconds. The characteristic sequence of the initial CBF decrease, followed by a positive DC shift and a delayed negative DC shift, is shown in Fig. 3 (240 minutes, CBF, and DC potential after cardiac arrest). The transient ischemic events in series I and II do not fit into the normal picture of ischemia. Their pattern is characterized by an almost simultaneous onset of CBF decrease and negative DC shift. An initial positive DC shift is missing (compare Fig. 3 [80 versus 240 minutes]). The probability of CSD occurrence was increased by our experimental design since [K+]A CS F was increased to 35 mmollL' Therefore, we hypothesized that the negative DC shift was caused by a spreading depression mechanism, and the transient ischemia was a paradoxical CBF response to CSD.
To prove this hypothesis, in series III, we tested whether CSD induces transient ischemia under the con dition of brain topical Hb (2 mmol/L) and increased
[K+]A CS F (20 mmollL; n = 4). The CSD was elicited by KCI. When CSD arrived at the closed parietal window, CBF and DC changes were measured. A typical experi ment is shown in Fig. 3 . At physiologic ACSF, CSD induced CSH (289 ± 53%) and a negative DC shift of -2.8 ± 1.5 mV ( Fig. 3 : 0 minutes). Superfusion of Hb and physiologic [K+]A CS F decreased CBF to 61 ± 20% (P < 0.1), reduced CSH to 154 ± 67% (P < 0.1), and in creased the DC potential significantly to -6.0 ± 1.8 m V (P < 0.05) ( Fig. 3 : 50 minutes). A transient ischemia was not observed with one exception. When [K+]A CS F was increased from 3 to 20 mmollL during continued super fusion with Hb, CSD induced transient ischemic events in all animals (amplitude of negative DC shift -9.0 ± 1.8 m V; duration of negative DC shift 28 ± 19 minutes; lowest CBF level 20 ± 20%; duration of hypoperfusion 25 ± 21 minutes) ( Fig. 3: 80 minutes) . The CBF level after the transient ischemia increased to 108 ± 54%. In Fig. 4 , the statistical analysis is summarized.
In series IV, the transformation of CSH into transient ischemia was confirmed by combined superfusion of the NOS inhibitor L-NA and increased [K+]A CS F at 20 10 min [wash in of hemoglobin 2x10-3
[: : : � 240 min [induction of cardiac arrest and brain death] minutes). The CBF level after the transient ischemia in creased to 177 ± 77%. To complement our studies, we measured the spreading of the CBF response in five ani mals with two laser-Doppler flow probes. As can be seen in Fig. 5B , CSH under physiologic conditions travels at similar speed (3.6 ± 0.7 mmlmin) as CSD-induced isch emia under the condition of NOS inhibition and in creased [K+]A C SF (3.4 ± 0.6 mmlmin). This finding clearly demonstrates the transformation of CSH into CSI.
In series IV through VIII, CBF and DC responses to CSD were compared during superfusion with either physiologic ACSF (series V, n = 5), or ACSF contain ing [K+]A C SF at 20 mmollL (series VI, n = 4), L-NA and [K+]A C SF at 3 mmollL (series VII, n = 10), L-NA and [K+]A C SF at 10 mmol/L) (series VIII, n = 6), or L-NA and [K+]A C SF at 20 mmol/L (series IV, n = 19). The statistical analysis is summarized in Fig. 6 .
We found that both the NO'-lowering agent and an increase of [K+]A C SF to at least 20 mmollL are necessary for the induction of CSI (with one exception in series VIII). Thus, both the NO'-lowering agent and [K+]A C SF are involved in the modulation of the vascular reactivity, which predisposes to CSI. In series VI, the CBF response to K+ after CSD was decreased compared with our ref erence values without preceding CSD (P < 0.05) (Dreier et aI., 1995) . This observation is consistent with de creased vascular reactivity after CSD (Lauritzen, 1984; Wahl et aI., 1987) . :;-(80 minutes). mmollL without L-NA increased the negative DC shift significantly (P < 0.05, series VI), whereas L-NA and [K+]A C SF at 3 mmollL did not (series VII). A small initial hypoperfusion, as described by Duckrow (1993) and Fabricius and colleagues (1995) , was found in 5 of 10 animals in series VII (L-NA and [K+]A C SF at 3 mmollL) and in 2 of 6 animals in series VIII (L-NA and [K+]A C SF at 10 mmollL). Both L-NA and [K+]A C SF at 3 mmollL reduced CSH by 34% (P < 0.05, series VII). In seven animals of series VII, we compared Ca 2 + -dependent NOS activity in the cortex superfused with L-NA with the contralateral hemisphere. The NOS activity in the contralateral cortex was 10.2 ± 4.4 pmollL/min/mg pro tein; NOS activity in the L-NA-treated cortex was 0.9 ± 0.6 pmollL/min/mg protein. Thus, inhibition of NOS ac tivity with L-NA was 91 %.
In series IX, we investigated the effect of nimodipine (2 /-Lg/kg body weight/min intravenously) on CSI (n = 4). A typical experiment is shown in Fig. 7 . Under physi ologic conditions, CSD induced CSH ( Fig. 7: 0 minutes) . Later, during superfusion with combined NOS inhibition and [K+]A C SF at 20 mmollL, CSD induced CSI ( Fig. 7: 180 minutes). Administration of nimodipine reestab lished an almost normal CBF response to CSD despite continued NOS inhibition and [K+]A C SF at 20 mmollL ( Fig. 7: 300 minutes) . In contrast, the vehicle control with alcohol (23.7 volume percent) showed an increase of CSI, which was not statistically significant (n = 4). The statistical analysis is shown in Fig. 8 . To investigate whether CSI may have potential to cause tissue damage, in series X, we compared the pat tern of oxygen free radical production during CSH with that of CSI. The CSH did not change radical production, whereas CSI produced a pattern typical of ischemia and reoxygenation (initial dip by -56 ± 22% followed by increase above baseline to +284 ± 58% , Fig. 9 , n = 4).
DISCUSSION
The effect of NOS inhibition on the CBF response to CSD is controversial. Duckrow (1993) demonstrated a modulation of the CBF response with a short initial hy poperfusion and an insignificant reduction of CSH in the awake rat by NOS inhibition. The difference of the mean values of CSH between the untreated group and the group treated with N-nitro-L-arginine-methyl-ester was more pronounced than in our study, but the statistical methods differ and his sample size was smaller. This may explain the statistical difference between our study and the study by Duckrow. Fabricius and others (1995) confirmed the short initial hypoperfusion in the anesthe tized rat but did not find a reduction of CSH. Zhang and coworkers (1994) and Wolf and associates (1996) did not observe any effect of NOS inhibition on CSH in the anesthetized rat. Goadsby and associates (1992) reported a complete block of CSH in the anesthetized cat but without preceding hypoperfusion. Colonna and others (1997) reported a reduction of CSH in the anesthetized rabbit. Wahl and colleagues (1994) described a signifi cant reduction of CSD-induced pial arteriolar dilation in the anesthetized cat, and Colonna and associates (1994) in the rabbit. In our study, both NO' scavenging and NOS inhibition reduced CSH by approximately 40% and pro voked a short initial hypoperfusion in some animals. The reason for the controversial results concerning NOS in hibition on CSH are not clear. Differences in anesthesia, species, preparation, or the route and time of drug appli cation may be responsible (Zhang et aI., 1994) . We em phasize that within the same laboratory using the same anesthesia and similar animals, systemic NOS inhibition with L-NA did not affect CSH (Wolf et aI., 1996) , but in this study, brain topical L-NA reduced CSH. However, 
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t�' 0 Duckrow (1993) also used systemic NOS inhibition and observed effects similar to this study. Therefore, a defi nite explanation cannot be given. Hypothetically, NO may have a low threshold at which NO' deprivation be comes effective. In this study, NOS inhibition was 91 %, which was higher than the effect reported by Zhang and colleagues (1994) . This hypothesis could be tested by combined topical application of Hb and NOS inhibitor or an increased concentration of NOS inhibitor when no effect is observed in a certain model. The cranial window must be large to avoid interfering effects by neighboring naive cortical areas. A threshold effect would point to a permissive action of NO' during CSD rather than ago nist-induced NOS activation (see later at the parietal window. Instead, at a 5-mm distance from the parietal window, CSD was elicited at will by KCI application, When CSD arrived at the parietal window, CBF and DC response were measured. Although CSD induced a CSH under physiologic conditions, cortical spreading ischemia (CSI) was induced by the combina tion of the NO'-lowering agent and [K+]A CS F at 20 mmoll L. Spreading of CSI was measured with two laser Doppler flow probes and was identical to spreading of CSH.
The generation of CSI depends on a decrease of the NO' level. This was shown indirectly by two different NO'-lowering agents, N-Nitro-L-arginine is an N substituted L-arginine analogue that inhibits the NOS (Iadecola et aI., 1994a) . Hemoglobin binds NO' with an affinity 1500 times higher than its affinity for oxygen (Gibson and Roughton, 1957) at its heme iron and reac tive sulfhydril groups at cysteine f3 93. Deoxygenation causes transition of S-nitroso-hemoglobin from the R(oxygenated) to the TCdeoxygenated) structure. The S nitroso-hemoglobin contracts blood vessels in the R structure while it relaxes them in the T structure. The vasodilation in the T structure is dependent on glutathi one and results from release of NO' from the binding at cysteine f3 93 (Stamler et aI., 1997; Jia et aI., 1996) . Thus, erythrocytes may exert a delicate action on vascular tone caused by NO' binding and release by Hb, dependent on oxygen tension. When Hb is released into the extracel lular space by hemolysis, the fine-tuned regulation is lost, and Hb acts essentially as a NO" scavenger (Perutz, 1996) . The evolutionary advantage likely is a protracted control of bleeding by strong vasoconstriction. Thus, free CBFcs, �, lowest CBF level during cortical spreading ischemia; CBFcs, duration, duration of CSI; CBF pre D, resting CBF level immediately before CSD; CBFs P ike ., highest CBF level during cortical spreading hyperemia or highest reperfusion level after cortical spreading ischemia; DC 1m, negative DC shift; *, level of significance of at least P < 0.05. Bars indicate mean value ± SD.
Concentrations in moill.
Hb injected into the subarachnoid space decreases cGMP in the vascular walls to levels similar to that produced by the NOS inhibitor N-nitro-L-arginine-methyl-ester (Ed wards et ai., 1992), causing acute vasoconstriction (Pe truk et ai., 1972) and reduction in CBF (Watkins et ai., 1994) . The decrease of CBF by free Hb in our study is consistent with these findings. During CSD, stimulation of NOS by increased intra cellular calcium may occur. Thus, NOS inhibition and NO' scavenging may interfere with the CBF response to CSD by inhibition of a NO' concentration peak during CSD. On the other hand, decrease of the basal NO' level may abolish the permissive function of NO' for other vasodilators. A permissive function was reported, for ex ample, for CO 2 , K+, and alpha 2-adrenoceptor-mediated vasodilation (ladecola et ai., 1994b; ladecola and Zhang, 1996; Bryan et ai., 1995; Dreier et aI., 1995) . Suggestion of a permissive effect of NO' during CSD was provided by Colonna et al. (1997) . They suggested neuronal NOS as the source of NO" for this effect, since 7-nitroindazo1e reduced CSH similar to L-NA. Whether endothelial NOS is not inhibited by 7-nitroindazole is controversial (Fab ricius et aI., 1996) .
The dependence of CST on the artificial increase of [K+1Acs F to 20 mmolfL is surprising, since [K+lo in creases in the cortex to 60 mmolfL during normal CSD (Kraig and Nicholson, 1978; Hansen et aI., 1980) . By an unknown mechanism, the increase of [K+]A CSF may po tentiate the small initial hypoperfusion that is induced by NO -lowering agents (Duckrow, 1993; Fabricius et aI., 1995) . The increase of the subarachnoid DC potential by increased [K+hc S F indicates a decrease of the electrical resistance between cortex and subarachnoid space. Elec trical coupling of the cortical and pial extracellular space may have implications for vascular ion channels during CSD. The direct effect of K+ on cerebral circulation is complex. Tn concentrations below 20 mmolfL, it acts as a vasodilator through inward rectifier K+ channels, and above 20 mmol/L, as a vasoconstrictor (Edwards et aI., 1988; McCulloch et aI., 1982; Kuschinsky et aI., 1972) . A synergistic vasodilating effect of mildly increased [K+L and sodium nitroprusside was reported for the rat aorta (Rapoport and Murad, 1983) . Consistently, vaso constriction by highly increased [K+lo was attenuated by sodium nitroprusside (Rapoport et ai., 1985) . An attenu ation of K+ induced vasoconstriction by NO' also was shown in the canine basilar artery (Minato et aI., 1995) . In contrast, the effect of increased [K+]o on NO' mediated cerebral vasodilation is only marginal. Al though NO"-induced smooth muscle hyperpolarizations in the rabbit basilar artery (Plane and Garland, 1994) and middle cerebral artery (Parsons et aI., 1991) are antago nized by high levels of [K+]o' smooth muscle relaxation is not. The hyperpolarization is caused by activation of potassium channels and therefore dependent on [K+Jo. However, the independence of the NO'-mediated smooth muscle relaxation from [K+] o supports that NO' is an efficient antagonist against K+ -induced vasoconstriction. Therefore, a decrease of the NO' level may promote acute vasoconstriction by the CSD-induced extracellular K+ -peak, thus producing hypoperfusion and CSI. Further vasoconstrictors besides K+ that are involved in the vas cular response to CSD are prostaglandins (Shibata et aI., 1991; Meng et aI., 1995) . The NO' antagonizes different potent vasoconstrictors (e.g., endothelins and serotonin). In addition, interference of decreased NO' levels or in creased subarachnoid K+ levels with vasodilation (e.g., by CGRP from the trigeminovascular system) (Colonna et aI., 1994; Wahl et aI., 1994) is conceivable.
Both the depolarization and the CBF response of CSI take much longer than normal CSD. This finding may be explained by the depolarization-induced ischemia. Under these conditions, the Na+-K+ ATPase fails to return the increased extracellular K+ ions into the cells (Rosenthal and Somjen, 1973; Mayevsky et aI., 1982) . Thus, repo larization does not occur and a vicious circle with vaso constriction and ischemia is established. Tn summary, depolarization, in the case of CSI, is not the result but the cause of ischemia in contrast to anoxic depolarization or periinfarction depolarization (Nedergaard and Astrup, 1986; Back et aI., 1994) . Failure of repolarization is simi lar in CAl and classic ischemia but it does not occur in normal CSD. If the primary event of CSD occurs in astrocytes (Nedergaard, 1994) , CSI is an astrocyte induced ischemia.
In series X, we confirm the data by Meng and Busija (1996) that the oxygen free radical production during normal CSD is not changed. The pattern of the oxygen free radical production during CSI is consistent with the typical pattern of transient cerebral ischemia in other in vivo models (Dirnagl et aI., 1995) and hypoxia in brain slices (Schreiber et aI., 1995) . This suggests that CSI may cause brain damage.
Clinical relevance of CSD is most frequently dis cussed in relation to classic migraine (Leao and Morison, 1945; Lauritzen and Olesen, 1984; Lauritzen, 1994) . Mi graine is associated in rare cases with strokes beginning with a migrainous aura that leads to a persistent neuro logic deficit (Broderick, 1997) . Such a sequence may be consistent with a CSD-induced ischemia. Complicated migraine and predominantly cortical brain infarcts are particularly impressive in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS syndrome) (Rosen et aI., 1990; Matthews et aI., 1991) . Association of some of the stroke-like episodes with seizures is interesting, smce seizure-like events and CSD often occur in the same pathophysiologic models, such as in the low Mg 2 + model in rat (Mody et a!., 1987) and human brain slices (A voli et a!., 1991) . A stroke principle based on disturbed cou pling between metabolism and cerebral blood flow may offer a pharmacologic treatment, such as nimodipine or blockade of CSD.
One of our experimental protocols suggests another connection with a clinical condition. In the erythrocyte, Hb (21.03 ± 0.75 mmollL; Stobbe, 1991) and K+ (102.4 ± 3.9 mmollL; Beutler, 1995) are the protein and ion, respectively, with the highest concentration. It is tempt ing to link the induction of CST by Hb and K+ in the subarachnoid space with DID after SAH. Closely asso ciated with the evolution of hemolysis after SAH, vaso spasm and DID develop (MacDonald and Weir, 1991) . The severity of this complication correlates with the amount of subarachnoid blood observed in fissures and cisterns in the computer tomogram (Fisher et aI., 1980; Brouwers et a!., 1993) . Of the patients without therapy, 30% develop DID after SAH, which cause death in 15% (Kassell et aI., 1990) . The pathomorphologic substrate of DID are cortical laminar and bell-shaped infarcts in over 90% (Stoltenburg-Didinger and Schwarz, 1987; Stolten burg-Didinger, 1997; Neil-Dwyer et aI., 1994) . The in farcts develop preferentially in areas covered with blood (Stoltenburg-Didinger and Schwarz, 1987; Stoltenburg Didinger, 1997) .
The mechanism of these infarcts is unknown. There is controversy whether structural changes of the vessels, vasoconstriction, or thrombosis may be responsible (Mohr et a!., 1992) . Vasoconstriction by free Hb as a single factor is not sufficient to induce ischemia (White , 1987) . A more complex mechanism is likely. In intracerebral hematomas, [K+]o can increase with a delay from 3 to 50 mmollL (Ohta et aI. 1983 ). Thus, the nec essary elements of CSI, Hb, and K+ may be present in the subarachnoid blood clot when hemolysis occurs after SAH.
Metaanalysis of seven randomized, double-blind, pla cebo-controlled trials shows that the L-type calcium channel blocker nimodipine decreases the risk of poor outcome in patients with aneurysmal SAH by 42% (Tettenborn and Dycka, 1990) . This effect results from the decrease of DID but not from angiographically vis ible vasospasm (Allen et aI., 1983; Espinosa et aI., 1984; Petruk et aI., 1988) . The transformation of CSI back to an almost normal CSH by nimodipine may further strengthen a link to the cortical infarcts after SAH. In terestingly, nimodipine blocks K+ -and serotonin- ::::. 0 induced vasoconstriction efficiently, but vasoconstriction by Hb or prostaglandins is antagonized poorly (Towart, 1981; Nosko et aI., 1986) . This may indicate a role of CSD-induced extracellular K+ rise or serotonin release for the acute CBF decrease of CSI.
The first combined recording of DC potential, [K+]o' and CBF changes in a human, typical of CSD, were reported by Mayevsky and colleagues (1996) in 1 of 14 patients with hemorrhagic brain trauma. During their ob servation period, the recorded spreading depressions showed a transition from a normal CBF response to a CBF response with "initial hypoperfusions." The first CBF responses with initial hypoperfusion of the patient were similar to the CBF responses during NOS inhibition and normal subarachnoid K+ in the rat reported by Duck row (1993) . With time, the initial hypoperfusions in the patient became deeper and longer, and the following hy- A typical experiment of series X is shown. In the upper plot, the oxygen free radical production is measured by enhanced chemiluminescence during normal CSD. No change of the radical production is observed. In the lower plot, the oxygen free radical production is measured during cortical spreading ischemia. In the lower plot, during CSI, the typical radical production pattern of transient ischemia and reoxygenation is characterized by an ini tial dip dur ing ischemia followed by free radical burst during reperfusion. The DC potential was simultaneously measured by a kalomelelectrode positioned frontally, at a distance from the closed window. Therefore the DC potentials of the two plots are similar.
perperfusion decreased in amplitude and increased in du ration. Although the initial hypoperfusions of the patient remained less pronounced than during CSI, a relation of both may be possible. Mayevsky and colleagues (l996) recorded at the right frontal cortex, and the computed tomography scan revealed a contusional hemorrhage at the right parietal cortex.
In summary, we have shown that during CSD there exists a complex relation between extracellular K+ and NO'. Under normal conditions, CSD produces hyper emia. When levels of NO' are decreased and subarach noid K+ is increased, CSD produces long-lasting CSI by induction of acute microcirculatory vasospasm caused by disturbed coupling between metabolism and CBF. We speculate the DID after subarachnoid hemorrhage, a con dition in which K+ and the NO' scavenger Hb are re leased into the subarachnoid space, may be related to CST.
